Aehr Test Systems (AEHR)
NASDAQ: AEHR
· Real-Time Price · USD
8.88
0.05 (0.57%)
At close: May 23, 2025, 3:59 PM
8.80
-0.96%
After-hours: May 23, 2025, 05:05 PM EDT
Aehr Test Systems Revenue Breakdown
| Period Ending | May 31, 2024 | May 31, 2021 | May 31, 2020 | May 31, 2019 |
|---|---|---|---|---|
| Contactors Revenue | 37.56M | 5.84M | 10.78M | 6.15M |
| Contactors Revenue Growth | +543.48% | -45.87% | +75.24% | n/a |
| Services Revenue | 4.49M | 3.51M | 3.41M | 5.34M |
| Services Revenue Growth | +27.78% | +3.08% | -36.13% | n/a |
| Systems Revenue | 24.17M | 7.25M | 8.1M | 9.57M |
| Systems Revenue Growth | +233.37% | -10.48% | -15.34% | n/a |
Revenue by Geography
| Period Ending | May 31, 2024 | May 31, 2021 | May 31, 2020 | May 31, 2019 |
|---|---|---|---|---|
| Asia Revenue | 58.08M | 11.07M | 7.56M | 5.65M |
| Asia Revenue Growth | +424.44% | +46.56% | +33.78% | n/a |
| Europe Revenue | 4.61M | 140K | 1.19M | 1.94M |
| Europe Revenue Growth | +3192.86% | -88.25% | -38.61% | n/a |
| United States Revenue | 3.53M | 5.39M | 13.54M | n/a |
| United States Revenue Growth | -34.42% | -60.23% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Feb 28, 2025 | Nov 29, 2024 | Aug 30, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 30, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.16M | 4.64M | 4.56M | 3.76M | 3.06M | 3.52M | 3.41M | 3.59M | 3.25M | 2.88M | 2.52M | 2.99M | 2.61M | 2.49M | 1.95M | 1.9M | 1.64M | 1.5M | 1.51M | 1.67M | 1.89M | 2.16M | 1.81M | 2.02M | 1.85M | 1.98M | 1.88M | 1.82M | 1.83M | 1.85M | 1.79M | 1.91M | 1.72M | 1.71M | 1.72M | 1.72M | 1.7M | 1.71M | 1.84M | 1.53M | 1.58M |
| Selling, General, and Administrative Revenue Growth | +11.32% | +1.73% | +21.35% | +22.62% | -12.93% | +3.20% | -4.96% | +10.37% | +13.04% | +13.86% | -15.64% | +14.59% | +4.94% | +27.44% | +2.57% | +15.89% | +9.46% | -0.86% | -9.56% | -11.48% | -12.33% | +19.30% | -10.41% | +9.08% | -6.42% | +5.22% | +3.47% | -0.71% | -1.35% | +3.52% | -5.98% | +10.50% | +1.00% | -0.52% | -0.35% | +1.59% | -1.05% | -7.15% | +20.90% | -3.66% | n/a |
| Research and Development Revenue | 3.14M | 2.28M | 2.36M | 2.15M | 2.14M | 1.97M | 2.46M | 2.25M | 1.83M | 1.55M | 1.5M | 1.66M | 1.53M | 1.31M | 1.32M | 1.03M | 903K | 820K | 900K | 854K | 845K | 795K | 892K | 1.12M | 931K | 986K | 1.12M | 1.1M | 1.04M | 1.09M | 955K | 1.31M | 1.25M | 1.04M | 1.06M | 1.05M | 1.29M | 923K | 1.06M | 967K | 1.03M |
| Research and Development Revenue Growth | +37.96% | -3.60% | +9.76% | +0.56% | +8.47% | -19.74% | +9.05% | +22.98% | +18.12% | +3.54% | -9.49% | +8.24% | +16.45% | -0.61% | +28.38% | +13.95% | +10.12% | -8.89% | +5.39% | +1.07% | +6.29% | -10.87% | -20.36% | +20.30% | -5.58% | -11.65% | +1.82% | +5.38% | -4.59% | +14.14% | -27.04% | +4.89% | +20.00% | -1.89% | +1.34% | -19.10% | +40.09% | -13.09% | +9.82% | -6.21% | n/a |